Your browser doesn't support javascript.
loading
PSA Kinetics as Prognostic Markers of Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Acetate.
España, Sofia; Ochoa de Olza, Maria; Sala, Nuria; Piulats, Josep Maria; Ferrandiz, Ulises; Etxaniz, Olatz; Heras, Lucia; Buisan, Oscar; Pardo, Juan Carlos; Suarez, Jose F; Barretina, Pilar; Comet, Josep; Garcia Del Muro, Xavier; Sumoy, Lauro; Font, Albert.
Afiliación
  • España S; Catalan Institute of Oncology, Medical Oncology Department, University Hospital Germans Trias I Pujol, Badalona, Spain.
  • Ochoa de Olza M; Catalan Institute of Oncology, Medical Oncology Department, Bellvitge University Hospital, Hospitalet De Llobregat, Spain.
  • Sala N; Catalan Institute of Oncology, Medical Oncology Department, University Hospital Josep Trueta, Girona, Spain.
  • Piulats JM; Catalan Institute of Oncology, Medical Oncology Department, Bellvitge University Hospital, Hospitalet De Llobregat, Spain.
  • Ferrandiz U; Catalan Institute of Oncology, Medical Oncology Department, University Hospital Germans Trias I Pujol, Badalona, Spain.
  • Etxaniz O; Catalan Institute of Oncology, Medical Oncology Department, University Hospital Germans Trias I Pujol, Badalona, Spain.
  • Heras L; Catalan Institute of Oncology, Medical Oncology Department, Bellvitge University Hospital, Hospitalet De Llobregat, Spain.
  • Buisan O; Medical Oncology Department, Hospital Sant Joan Despí Moisès Broggi, Barcelona, Spain.
  • Pardo JC; Urology Department, University Hospital Germans Trias I Pujol, Badalona, Spain.
  • Suarez JF; Catalan Institute of Oncology, Medical Oncology Department, University Hospital Germans Trias I Pujol, Badalona, Spain.
  • Barretina P; Urology Department, Bellvitge University Hospital, Hospitalet de LLobregat, Spain.
  • Comet J; Catalan Institute of Oncology, Medical Oncology Department, University Hospital Josep Trueta, Girona, Spain.
  • Garcia Del Muro X; Urology Department, University Hospital Josep Trueta, Girona, Spain.
  • Sumoy L; Catalan Institute of Oncology, Medical Oncology Department, Bellvitge University Hospital, Hospitalet De Llobregat, Spain.
  • Font A; High Content Genomics & Bioinformatics Unit, Germans Trias I Pujol Research Institute (IGTP), Program of Predictive and Personalized Medicine of Cancer (PMPPC), Campus Can Ruti, Badalona, Spain.
Cancer Manag Res ; 12: 10251-10260, 2020.
Article en En | MEDLINE | ID: mdl-33116879
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Manag Res Año: 2020 Tipo del documento: Article País de afiliación: España Pais de publicación: Nueva Zelanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Manag Res Año: 2020 Tipo del documento: Article País de afiliación: España Pais de publicación: Nueva Zelanda